Collier Creek Holdings to Combine with Utz Brands, Inc.
by Kristi Marvin on 2020-06-05 at 11:17am

Collier Creek looking like a snack!

The rumors were true….Collier Creek Holdings (CCH) announced this morning that they have entered into a definitive agreement to combine with Utz Quality Foods, LLC, to create Utz Brands, Inc. Utz Brands will be a leading pure-play snack food platform in the U.S., and it is expected that upon closing Utz Brands will trade under the ticker symbol “UTZ” on the New York Stock Exchange.

As for the transaction details, Collier Creek intends to use the approximate $453 million of cash currently held in trust (assuming no redemptions) and the $35 million forward purchase of units to fund this deal, which will reduce Utz’s indebtedness to ~3.1x estimated 2020 Pro Forma adjusted EBITDA of $134 million.  It is anticipated that Utz Brands will have an initial enterprise value of approximately $1.56 billion or 11.6x its estimated 2021 PF Adjusted EBITDA.

The Rice and Lissette family, the founding family and owners of Utz, will retain more than 90% of its existing equity stake, which will represent more than 50% ownership in Utz Brands upon completion of the transaction.

Dylan Lissette, who has served as Utz’s CEO since 2013 and has worked at the Company for almost 25 years, will continue to lead the business along with the existing management team. Roger Deromedi, Collier Creek’s Co-Executive Chairman and former Chairman of Pinnacle Foods and CEO of Kraft Foods, will become Chairman of Utz Brands.


Quick Takes: As someone who has been snacking pretty consistently during the pandemic, along with many other people, this transaction looks pretty tasty. You have an established, recognizable brand name and portfolio, but more importantly, Utz gets to go public with Roger Deromedi as Chairman.  Obtaining that kind of leadership is one of the best reasons to go public via a SPAC. If Utz were to go the traditional IPO route, they (presumably) wouldn’t have the advantage of having the experience and rolodex of a seasoned executive like Mr. Deromedi join their company.  And since Mr. Deromedi is a highly recognizable name in the space, having previously headed the public companies of Pinnacle Foods and Kraft Foods, that is a huge advantage for Utz.  This transaction does have a minimum cash closing condition of $300 million, but given that the CCH’s share price is already trading above $12.00, they should have very few (if any) redemptions, i.e., meeting $300 million shouldn’t be an issue.


CONFERENCE CALL INFORMATION

Collier Creek’s investor conference call and presentation discussing the transaction can be accessed by visiting www.netroadshow.com and entering the passcode Utz2020.

A transcript of the call will also be filed by Collier Creek with the SEC.


ADVISORS

  • Goldman Sachs and Sageworth are acting as financial advisors to Utz.
  • Citigroup, Credit Suisse, and BofA Securities are acting as capital markets advisors to Collier Creek.
  • Citigroup and Credit Suisse are acting as lead financial advisors.
  • BofA Securities and Nomura also serving as financial advisors to Collier Creek.
  • Cozen O’Connor is acting as legal counsel to Utz.
  • Kirkland & Ellis LLP is acting as legal counsel to Collier Creek.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

by Nicholas Alan Clayton on 2024-04-15 at 3:47pm

AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved